Article
Phosphoproteomic comparison of Pik3ca and Pten signalling identifies the nucleotidase NT5C as a novel AKT substrate.
Scientific reports - 6 Jan 2017
Moniz Larissa S, Surinova Silvia, Ghazaly Essam, Velasco Lorena Gonzalez, Haider Syed, Rodríguez-Prados Juan Carlos, Berenjeno Inma M, Chelala Claude, Vanhaesebroeck Bart
Abstract excerpt
To identify novel effectors and processes regulated by PI3K pathway activation, we performed an unbiased phosphoproteomic screen comparing two common events of PI3K deregulation in cancer: oncogenic Pik3ca mutation (Pik3caH1047R) and deletion of Pten. Using mouse embryonic fibroblast (MEF) models that generate inducible, low-level pathway activation as observed in cancer, we quantified 7566 unique phosphopeptides...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
